Article Text

Rare disease
Triple A syndrome: two novel mutations in the AAAS gene
  1. Susanne Thümmler1,
  2. Angela Huebner2,
  3. Elisabeth Baechler-Sadoul1
  1. 1
    Lenval Foundation-Children’s Hospital, Paediatric Department, 57 Avenue de la Californie, Nice, 06200, France
  2. 2
    Children’s Hospital, Technical University Dresden, Fetscherstrasse 74, Dresden, 01307, Germany
  1. Elisabeth Baechler-Sadoul, elisabeth.baechler{at}lenval.com

Summary

Triple A syndrome is a rare disease of autosomal recessive inheritance. It was first described in 1978. The typical triad includes adrenocorticotrophic-hormone-resistant glucocorticoid insufficiency, reduced or absent tearing (alacrima) and achalasia. But clinical symptoms can be extremely heterogeneous and of variable clinically expression. This report describes a 7-year-old boy with a 1 year history of fatigue and muscle weakness. Physical examination showed skin and mucosal hyperpigmentation, and hormonal analysis revealed isolated glucocorticoid function. Medical history was marked by megaoesophagus and achalasia. The absence of tears when crying had been noted since birth. In the presence of the classical triad, triple A syndrome was diagnosed. Clinical diagnosis was confirmed by molecular analysis of the AAAS gene on chromosome 12q13. The novel compound heterozygous mutation c.1304delA and c.1292-1294delTTCinsA was found.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests: none.

  • Patient consent: Patient/guardian consent was obtained for publication.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.